[Ip-health] Protests in Delhi as EU defends Big Pharma

Riaz K Tayob riaz.tayob at gmail.com
Sat Mar 5 16:01:42 PST 2011

[This in a context where the EU Parliament has issued a resolution not 
to have stuff in the deal that compromises access to medicines!]

Protests in Delhi as EU defends Big Pharma
3 March 2011

“Thousands march in India against EU trade deal,” headlines the 
EUobserver. With the EU on the verge of concluding a Free Trade 
Agreement (FTA) with India, its largest trading partner, HIV-positive 
protesters took to the streets of New Delhi on 2 March concerned that 
the union is seeking to put an end to the production of affordable 
life-prolonging drugs. Since negotiations opened in 2007, the EU has 
pushed for a “data-exclusivity” clause which would protect intellectual 
property rights with respect to drugs. “European drug manufacturers 
complain that many of their patented products are frequently undercut by 
generics produced in India,” the Brussels website notes. Data 
exclusivity would mean that “clinical trial data filed by one company 
could not be relied upon by other companies,” critics argues. “As a 
result, the need for each firm to produce its own clinical trial tests 
would dramatically increase the price of medicines.” According to Anand 
Grover, the UN Special Rapporteur on the Right to Health, "It would be a 
colossal mistake to introduce data exclusivity in India, when millions 
of people across the globe depend on the country as the pharmacy of the 
developing world.”


More information about the Ip-health mailing list